- Meeting abstract
- Open Access
Haematological malignancy on the ICU - can we identify survivors?
Critical Care volume 5, Article number: P240 (2001)
Early and accurate identification of patients with a haematological malignanacy, with a poor outcome on the intensive care, would allow appropriate utilisation of limited resources.
The aim of our study was to evaluate factors that would help predict survivors in-patients with haematological malignancy who required admission to intensive care unit.
We retrospectively analysed data on patients with haematological malignancy admitted to the intensive care over a 5 year period.
We identified 65 haematological patients, admitted for >1 day to the intensive care. (Table overleaf.)
There were differences in terms of the demographic data or severity of illness scores on day 1, ie APACHE II and organ failure scores, organ failure days and the P/F ratios between the two groups survivors and non-survivors. However by day 3, there was a significant difference between the survivors and the non-survivors in terms of improvement of the APACHE II and organ failure scores, organ failure days and the P/F ratios.
An improved outcome was associated with an improvement in the day 3 APACHE II and organ failure scores, organ failure days and the P/F ratios, however a failure to do so was associated with a poorer outcome. All survivors could be identified by day 3 of ICU admission.
Gruson D, Hilbert G, Vargas F, et al.: Severe respiratory failure requiring ICU admission in bone marrow transplant recipients. Eur Respir J 1999, 13: 883-887. 10.1183/09031936.99.13488399
About this article
Cite this article
Shah, S., Mehta, P., Read, M. et al. Haematological malignancy on the ICU - can we identify survivors?. Crit Care 5, P240 (2001). https://doi.org/10.1186/cc1305
- Public Health
- Intensive Care Unit
- Emergency Medicine
- Demographic Data
- Organ Failure